All In Biotech

Free tool

FAERS Monitor: Lexapro

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021323 or its brand name (Lexapro, Escitalopram Oxalate). Reports on generic versions are filed under their own applications.

Reports

127,231

Serious

84,617

67% of reports

Hospitalization

39,685

Death reported

10,109

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea8,649
  • fatigue8,646
  • drug ineffective8,210
  • headache6,442
  • diarrhoea6,305
  • anxiety6,260
  • depression5,814
  • dizziness5,723
  • off label use5,573
  • pain5,306
  • fall5,050
  • vomiting4,742
  • dyspnoea4,725
  • insomnia4,124
  • asthenia4,009

Reports by year received

View as table
YearReports
20041,788
20052,181
20062,103
20072,484
20082,407
20093,301
20104,363
20114,140
20124,641
20133,839
20144,290
20156,534
20168,096
20177,350
20188,674
20198,985
20208,696
20217,186
20227,544
20237,524
20247,739
20257,551
20265,814

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,926,928 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
depressionSignal5,8144.34.214,549
anxietySignal6,2603.73.612,200
insomniaSignal4,1242.62.53,992
fallSignal5,0502.52.54,681
dizziness5,7231.91.92,500
fatigue8,6461.81.83,437
nausea8,6491.81.83,255
asthenia4,0091.81.71,354
headache6,4421.71.71,919
vomiting4,7421.71.61,303
diarrhoea6,3051.61.61,531
pain5,3061.41.4705
dyspnoea4,7251.41.3510
off label use5,5731.11.015
drug ineffective8,2101.01.08

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.